May 17, 2022 Nimble Therapeutics Announces Achievement of Development Milestones from Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each
April 13, 2022 bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that
January 25, 2022 AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub
January 25, 2022 Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank
January 5, 2022 Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and
December 14, 2021 Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions SALT LAKE CITY, UTAH (December 14, 2021) – Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization,
December 13, 2021 Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners MARLBOROUGH, Mass.,
November 15, 2021 Cell Microsystems Completes $10M Growth Financing Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative
October 4, 2021 Specific Diagnostics Announces the First Purchase Orders in Europe October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent
September 14, 2021 Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc. LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a